Open Access
Issue
Vet. Res.
Volume 38, Number 6, November-December 2007
Page(s) 773 - 794
DOI http://dx.doi.org/10.1051/vetres:2007031
Published online 31 August 2007
How to cite this article Vet. Res. (2007) 773-794
References of  Vet. Res. 38 (2007) 773-794
  1. Anderson M., Blanchard P., The clinical syndromes caused by Salmonella infection, Vet. Med. (1989) 84:816-819.
  2. Bowersock T.L., Shalaby W.S.W., Levy M., Blevins W.E., White M.R., Borie D.L., Park K., The potential use of poly (methacrylic acid) hydrogels for oral administration of drugs and vaccines to ruminants, J. Control. Release (1994) 31:245-254 [CrossRef].
  3. Bowersock T.L., HogenEsch H., Suckow M., Guimond P., Martin S., Borie D., Torregrosa S., Park H., Park K., Oral vaccination of animals with antigens encapsulated in alginate microspheres, Vaccine (1999) 17:1804-1811 [CrossRef] [PubMed].
  4. Boyce J.D., Wilkie I., Harper M., Paustian M.L., Kapur V., Adler B., Genomic scale analysis of Pasteurella multocida gene expression during growth within the natural chicken host, Infect. Immun. (2002) 70:6871-6879 [CrossRef] [PubMed].
  5. Bridson E.Y., The Oxoid Manual, Oxoid, Hampshire, 1998, pp. 3:16-17.
  6. Carlton B.C., Brown B.J., Gene Mutation, in: Gerhardt P., Murray R.G., Costilow R.N., Nester E.W., Wood M.W., Krieg N.R., Phillips G.B. (Eds.), Manual of Methods for General Bacteriology, American Society for Microbiology, Washington, DC, 1981, pp. 232-234.
  7. Chambers P.G., Lysons R.J., The inhibitory effect of bovine rumen fluid on Salmonella typhimurium, Res. Vet. Sci. (1979) 26:273-276 [PubMed].
  8. Cox E., Verdonck F., Vanrompay D., Goddeeris B., Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa, Vet. Res. (2006) 37:511-539 [CrossRef] [PubMed] [EDP Sciences].
  9. DesBordes C.K., Welch J.G., Influence of specific gravity on rumination and passage of indigestible particles, J. Anim. Sci. (1984) 59:470-475.
  10. Ferraro M.J., Craig W.A., Eliopoulos G., Fung-Tomc J., Hansen S.L., Hecht D.W., Hindler J., Reller L.B., Sahm D.F., Swenson J.M., Tenover F.C., Testa R.T., Wilker M.A., Performance standards for antimicrobial susceptibility testing; Eighth Informational Supplement, NCCLS (1998) 18:1-35.
  11. Gerdts V., Mutwiri G.K., Tikoo S.K., Babiuk L.A., Mucosal delivery of vaccines in domestic animals, Vet. Res. (2006) 37:487-510 [CrossRef] [PubMed] [EDP Sciences].
  12. Griggs D.J., Gensberg K., Piddock L.J.V., Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals, Antimicrob. Agents Chemother. (1996) 40:1009-1013 [PubMed].
  13. Guyton A.C., Hall J.E., Textbook of medical physiology, Elsevier Saunders, Pennsylvania, 2006, pp. 802-807.
  14. Hinton M., Salmonella dublin abortion in cattle: studies on the clinical aspects of the condition, Br. Vet. J. (1974) 130:556-562 [PubMed].
  15. Jin D.J., Gross C.A., Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance, J. Mol. Biol. (1988) 202:45-58 [CrossRef] [PubMed].
  16. Kaye D., Palmieri M., Rocha H., Effect of bile on the action of blood against Salmonella, J. Bacteriol. (1966) 91:945-952 [PubMed].
  17. Kodama C., Eguchi M., Sekiya Y., Yamamoto T., Kikuchi Y., Matsui H., Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate, Microbiol. Immunol. (2005) 49:1035-1045 [PubMed].
  18. Levine M.M., Dougan G., Optimism over vaccines administered through mucosal surfaces, Lancet (1998) 351:1375-1376 [CrossRef] [PubMed].
  19. Linde K., Beer J., Bondarenko V., Stable Salmonella live vaccine strains with two or more attenuating mutations and any desired level of attenuation, Vaccine (1990) 8:278-282 [CrossRef] [PubMed].
  20. Mastroeni P., Cahill B., Simmons C., Dougan G., Vaccines against gut pathogens, Gut (1999) 45:633-635 [PubMed].
  21. Matsui H., Suzuki M., Isshiki Y., Kodama C., Eguchi M., Kikuchi Y., Motokawa K., Takaya A., Tomoyasu Y., Yamamoto T., Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar Typhimurium, Infect. Immun. (2003) 71:30-39 [CrossRef] [PubMed].
  22. McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P., Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D., Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E., Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R., Wilson R.K., Complete genome sequence of Salmonella enterica serovar Typhimurium LT2, Nature (2001) 413:852-856 [CrossRef] [PubMed].
  23. Miles A.A., Misra S.S., Irwin J.O., The estimation of the bactericidal power of the blood, J. Hyg. Camb. (1938) 38:732-749.
  24. Oram M., Fisher M., 4-quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction, Antimicrob. Agents Chemother. (1991) 35:387-389 [PubMed].
  25. Quinn P.J., Carter M.E., Markey B.K., Carter G.R., Clinical Veterinary Microbiology, Mosby International, Philadelphia, 1999, pp. 226-236.
  26. Reed L.J., Muench H., A simple method of estimating fifty per cent endpoints, Am. J. Hyg. (1937) 27:493-497.
  27. Richardson A., Salmonella dublin infection in cattle, Aust. Vet. J. (1974) 50:463-466.
  28. Segall T., Lindberg A.A., Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9, 12) hybrid expressing O4, 12 protects against S. dublin (O9, 12) but not against Salmonella typhimurium (O4, 5, 12), Infect. Immun. (1993) 61:1222-1231 [PubMed].
  29. Smith B.P., Reina-Guerra M., Hoiseth S., Stocker B.A., Habasha F., Johnson E., Merritt F.F., Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves, Am. J. Vet. Res. (1984) 45:59-66 [PubMed].
  30. Smith B.P., Reina-Guerra M., Stocker B.A., Hoiseth S., Johnson E.H., Vaccination of calves against Salmonella dublin with aromatic-dependent Salmonella typhimurium, Am. J. Vet. Res. (1984) 45:1858-1861 [PubMed].
  31. Smith B.P., Salmonellosis, in: Reinhardt R.W. (Ed.), Large animal internal medicine, C.V. Mosby, St. Louis, 1990, pp. 818-822.
  32. Smith B.P., Dilling G.W., Roden L.D., Stocker B.A., Vaccination of calves with orally administered aromatic-dependent Salmonella dublin, Am. J. Vet. Res. (1993) 54:1249-1255 [PubMed].
  33. Thanassi D.G., Cheng L.W., Nikaido H., Active efflux of bile salts by Escherichia coli, J. Bacteriol. (1997) 179:2512-2518 [PubMed].
  34. Tizard I.R., Immunology, Saunders College Publishing, Philadelphia, 1995, pp. 347-358.
  35. Uren T., Wijburg O.L.C., Simmons C., Johansen F., Brandtzaeg P., Strugnell R., Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies, Eur. J. Immunol. (2005) 35:180-188 [PubMed].
  36. Van Velkinburgh J.C., Gunn J.S., PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp., Infect. Immun. (1999) 67:1614-1622 [PubMed].
  37. Watts J.L., Chengappa M.M., Cole J.R., Cooper J.M., Hoffman L.J., Inzana T.J., Owens W.E., Shryock T.R., Thornsberry C., Walker R.D., Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; tentative standard, NCCLS (1997) 17:1-63.
  38. World Organization for Animal Health, Manual of diagnostic tests and vaccines for terrestrial animals, OIE, Paris, 2004, pp. 1018-1032.
  39. Wray C., McLaren I., Further studies on the use of Gal E mutants of Salmonella typhimurium in calves: oral vaccination and toxicity studies, J. Vet. Med. B (1987) 34:22-29.
  40. Wray C., Davies R.H., Salmonella infections in cattle, in: Wray C., Wray A. (Eds.), Salmonella in domestic animals, CABI Publishing, New York, 2000, pp. 169-190.
  41. Yethon J.A., Gunn J.S., Ernst R.K., Miller S.I., Laroche L., Malo D., Whitfield C., Salmonella enterica serovar Typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence in vivo, Infect. Immun. (2000) 68:4485-4491 [CrossRef] [PubMed].
  42. Yoshida H., Bogaki M., Nakamura M., Nakamura S., Quinolone resistant-determining region in the DNA gyrase gyrA gene of Escherichia coli, Antimicrob. Agents Chemother. (1990) 14:1271-1272.